NCT00186225已完成不适用
Stem Cell Transplantation From Matched Unrelated or Partially Matched Related Donors Using a Preparatory Regimen Consisting of Fractionated Total Body Irradiation (FTBI) and Cyclophosphamide (CY)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 250
- 试验地点
- 1
- 主要终点
- oxicity and efficacy of TBI and cyclophosphamide as preparation for hematopoietic cell transplantation from partially matched and unrelated donors.
研究概览
简要总结
To evaluate the use of unrelated donors for hematopoietic cell transplantation in the treatment of hematologic and lymphoid malignancies.
详细描述
Stem Cell Transplantation from Matched Unrelated or Partially Matched Related Donors Using a Preparatory Regimen Consisting of Fractionated Total Body Irradiation (FTBI) and Cyclophosphamide (CY). To administer high dose radio-chemotherapy followed by stem cell transplantation from a matched unrelated donor or a partially matched related donor.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 4 Weeks 至 50 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •acute leukemia
- •chronic leukemia
- •lymphoblastic lymphoma
排除标准
- •organ dysfunction
- •HIV positive
结局指标
主要结局
oxicity and efficacy of TBI and cyclophosphamide as preparation for hematopoietic cell transplantation from partially matched and unrelated donors.
次要结局
- Event Free Survival
- Overall Survival
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic DisordersVirus-Associated Hemophagocytic SyndromeHemophagocytic LymphohistiocytosisChediak-Higashi SyndromeGraft Versus Host DiseaseX-Linked Lymphoproliferative SyndromeFamilial Erythrophagocytic LymphohistiocytosisNCT00006056Fairview University Medical Center40
终止
2 期
Unrelated Donor Transplant for Malignant and Non-Malignant DisordersBone Marrow Failure SyndromesImmunodeficienciesHistiocytosisLymphomaLeukemiaNCT01050439Columbia University22
已完成
不适用
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem CellsHEMATOLOGIC MALIGNANCIESNCT00770523Cooperative Study Group A for Hematology52
招募中
2 期
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cellsSevere Aplastic AnemiaMDS (Myelodysplastic Syndrome)NCT01174108National Heart, Lung, and Blood Institute (NHLBI)120
终止
2 期
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerUnusual Cancers of ChildhoodChronic Myeloproliferative DisordersMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsLymphomaLeukemiaNCT00281879OHSU Knight Cancer Institute200